Gradient Investments LLC decreased its holdings in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 6.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 141,039 shares of the semiconductor company's stock after selling 9,128 shares during the period. Gradient Investments LLC's holdings in Lam Research were worth $46,333,000 at the end of the most recent reporting period.
Other hedge funds have also added to or reduced their stakes in the company. Bayban bought a new stake in shares of Lam Research in the 4th quarter valued at $26,000. Vermillion Wealth Management Inc. acquired a new stake in Lam Research in the first quarter worth $26,000. Cedar Mountain Advisors LLC increased its stake in Lam Research by 242.9% in the first quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company's stock valued at $26,000 after purchasing an additional 85 shares in the last quarter. Paladin Partners LLC bought a new stake in Lam Research in the second quarter valued at $26,000. Finally, University of Illinois Foundation acquired a new position in shares of Lam Research during the fourth quarter valued at about $30,000. 84.61% of the stock is currently owned by institutional investors.
More Lam Research News
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Lam Research is benefiting from continued investment in AI chips, advanced packaging and high-bandwidth memory (HBM), which is increasing demand for the company’s wafer-fabrication equipment. The stock is reportedly up about 73% this year and ranks highly among stocks with strong return on equity. Is Lam Research a Smart AI Stock Pick for Long-Term Investors?
- Positive Sentiment: Recent analysis continues to highlight Lam’s earnings growth, improving margins and consistent profitability. Its latest reported quarter exceeded consensus expectations, with revenue rising 30% year over year and EPS surpassing estimates, reinforcing the bullish fundamental case.
- Positive Sentiment: Zacks included Lam Research among chip stocks with dependable earnings that could benefit from the AI boom, alongside NVIDIA, Applied Materials and TSMC. This keeps LRCX prominent among investors seeking semiconductor exposure. 4 Top Chip Stocks With Dependable Earnings to Ride the AI Boom
- Neutral Sentiment: Lam Research is one of the most-watched stocks on Zacks, but the “trending stock” coverage reflects investor interest rather than a new company announcement or earnings catalyst. Lam Research Is a Trending Stock
- Negative Sentiment: Valuation remains the main risk. Analysts note that Lam trades at a premium to KLA relative to trailing free cash flow, so continued gains may require sustained AI-driven growth and execution. A modest premarket decline in Europe also points to some near-term caution. Lam Research vs. KLA
- Neutral Sentiment: One article references an abdominoplasty clinical trial while attributing it to Lam Research, which appears unrelated to the semiconductor-equipment company and should not be treated as relevant investment news.
Insider Buying and Selling at Lam Research
In other news, insider Ava Harter sold 5,000 shares of the firm's stock in a transaction on Monday, August 31st. The shares were sold at an average price of $302.46, for a total transaction of $1,512,300.00. Following the sale, the insider owned 42,462 shares in the company, valued at approximately $12,843,056.52. This trade represents a 10.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bethany Mayer sold 9,557 shares of Lam Research stock in a transaction on Wednesday, September 9th. The stock was sold at an average price of $314.74, for a total transaction of $3,007,970.18. Following the sale, the director directly owned 20,995 shares of the company's stock, valued at $6,607,966.30. This represents a 31.28% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 32,839 shares of company stock worth $10,644,740 over the last three months. 0.31% of the stock is owned by insiders.
Lam Research Price Performance
NASDAQ LRCX traded down $12.04 on Thursday, hitting $317.47. The stock had a trading volume of 3,683,911 shares, compared to its average volume of 10,696,479. Lam Research Corporation has a 52-week low of $131.02 and a 52-week high of $438.50. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.91 and a current ratio of 2.63. The company has a market capitalization of $397.29 billion, a price-to-earnings ratio of 55.28, a price-to-earnings-growth ratio of 1.32 and a beta of 1.85. The firm has a 50-day moving average of $310.02 and a 200-day moving average of $305.12.
Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.69 by $0.13. The company had revenue of $6.72 billion for the quarter, compared to the consensus estimate of $6.66 billion. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The firm's revenue was up 30.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.33 earnings per share. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Equities analysts expect that Lam Research Corporation will post 9.34 EPS for the current year.
Lam Research Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 14th. Investors of record on Wednesday, September 23rd will be paid a $0.33 dividend. This is an increase from Lam Research's previous quarterly dividend of $0.26. This represents a $1.32 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Wednesday, September 23rd. Lam Research's payout ratio is 22.92%.
Wall Street Analyst Weigh In
LRCX has been the subject of a number of research reports. Mizuho reduced their price objective on Lam Research from $370.00 to $365.00 and set an "outperform" rating for the company in a research note on Tuesday, August 25th. Oppenheimer restated an "outperform" rating and issued a $400.00 target price (up from $330.00) on shares of Lam Research in a report on Monday, June 15th. TD Cowen reiterated a "buy" rating and issued a $400.00 price objective (up from $340.00) on shares of Lam Research in a research note on Thursday, July 9th. Morgan Stanley restated an "overweight" rating and issued a $385.00 target price (up from $367.00) on shares of Lam Research in a research note on Monday. Finally, Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and set a $320.00 price target on shares of Lam Research in a research note on Thursday, July 30th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have given a Hold rating to the company's stock. According to MarketBeat.com, Lam Research presently has an average rating of "Moderate Buy" and an average price target of $364.59.
Read Our Latest Report on Lam Research
Lam Research Company Profile
(
Free Report)
Lam Research Corporation is a semiconductor equipment company that designs, manufactures, and services systems used in the fabrication of integrated circuits and other electronic devices. Its equipment supports key steps in the wafer manufacturing process, helping semiconductor producers create increasingly small and complex features on silicon wafers.
The company's portfolio includes systems for etch, deposition, wafer cleaning, surface preparation, and related manufacturing processes.
Featured Stories
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.